NCT03635866View on ClinicalTrials.gov

PET/MRI Study of Men With Highly Suspicious MRI Lesions That Showed no Clinically Significant Prostate Cancer Following MRI Fusion Targeted Biopsy

NACompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

January 2, 2019

Primary Completion Date

October 9, 2020

Study Completion Date

October 9, 2020

Conditions
Prostate Cancer
Interventions
DIAGNOSTIC_TEST

Fluciclovine PET/MRI

It is unknown how many negative MRFTBs of PI-RADS 4 lesions are false negative biopsies or false positive tests.

Trial Locations (1)

10016

New York University Langone Medical Center, New York

All Listed Sponsors
lead

NYU Langone Health

OTHER

NCT03635866 - PET/MRI Study of Men With Highly Suspicious MRI Lesions That Showed no Clinically Significant Prostate Cancer Following MRI Fusion Targeted Biopsy | Biotech Hunter | Biotech Hunter